CTOs on the Move


 
MedCAD is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Rapid Enrollment Solutions

Rapid Enrollment Solutions is a Solana Beach, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wellpoint Health

Wellpoint is a National Leader in providing organizations with integrated absence management and occupational health solutions and services.

Heartbeat Health

A new standard for virtual heart care. Heartbeat is a complete telehealth platform for cardiology that incorporates telemedicine, remote diagnostics, and digital heart health programs. Learn more

Cigna Global Health

Everything we do is around our mission to help you improve your health, wellbeing and peace of mind. We have extensive experience in managing varied and unique clinical and service situations worldwide. Our vast experience, coupled with our expertise, enables us to provide high standards of healthcare coverage, regardless of where you are in the world. Cigna International by the numbers: • Our international health insurance plans give you access to a global network of over 1.5 million hospitals, clinics and doctors. • Our employees serve over 160 million customers in key markets around the globe. • Our Customer Care Team is here for you 24/7, 365 days a year.

Immune Pharmaceuticals

Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.